Cargando…
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases
Immune mediated inflammatory diseases (IMIDs) are a heterogeneous group of debilitating, multifactorial and unrelated conditions featured by a dysregulated immune response leading to destructive chronic inflammation. The immune dysregulation can affect various organ systems: gut (e.g., inflammatory...
Autores principales: | Vetrano, Stefania, Bouma, Gerben, Benschop, Robert J., Birngruber, Thomas, Costanzo, Antonio, D’Haens, G. R. A. M., Frasca, Loredana, Hillenbrand, Rainer, Iversen, Lars, Johansen, Claus, Kaser, Arthur, Koenen, Hans J. P. M., Noehammer, Christa, Peyrin-Biroulet, Laurent, Raes, Jeroen, Ricotti, Leonardo, Rosenstiel, Philip, Satagopam, Venkata P., Schreiber, Stefan, Vermeire, Severine, Wollenberg, Andreas, Weidinger, Stephan, Ziemek, Daniel, Danese, Silvio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682955/ https://www.ncbi.nlm.nih.gov/pubmed/36439150 http://dx.doi.org/10.3389/fimmu.2022.1002629 |
Ejemplares similares
-
Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: Results up to Week 104 of the STARDUST trial
por: Panés, Julian, et al.
Publicado: (2023) -
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
por: Danese, Silvio, et al.
Publicado: (2016) -
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
por: Danese, Silvio, et al.
Publicado: (2021) -
Evolution of IL-23 Blockade in Inflammatory Bowel Disease
por: Danese, Silvio, et al.
Publicado: (2022) -
Tratado de entomología Imms
por: Richards, O. W.
Publicado: (1983)